# Estradiol

## Ladiol Gel 0.6mg/gmï¼Œ 30gm

##### 

| TAH Drug Code      | [ELAD](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ELAD)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Natural or surgical menopause, estrogen deficiencies; vasomotor disorders associated with menopause; tropic disorders caused by disturbances in ovarian secretions as in vag atrophy, kraurosis vulvae, female hypogonadism, castration in women, primary ovarian deficiency.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Apply 2.5gm daily (preferably on the abdomen) from day 1 to day 24 every month.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Malignant tumors of the breast or uterus. Pituitary tumors.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Cardiovascular: Edema (transdermal system, 0.5% to 13% ) Dermatologic: Application site irritation (transdermal spray, 1.3% ; transdermal system, 5.7% to 56.7% ), Chloasma, Hirsutism, Persistent erythema of skin (transdermal patch, 17% ), Pruritus (topical emulsion, 4% ; topical gel, 4.8% ) Endocrine metabolic: Weight change finding Gastrointestinal: Bloating symptom, Nausea, Vomiting Neurologic: Migraine Psychiatric: Depression (transdermal system, 1% to 8% ), Disturbance in mood Reproductive: Breast tenderness (topical gel, 2.5% to 8.8% ; transdermal spray, 5% to 7% ; transdermal system, 6.5% to 17.0% ), Disorder of menstruation, Leukorrhea, Swelling of breast, Vaginal discomfort (vaginal cream, 5% ; vaginal ring, 5% ), Withdrawal bleeding |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

